يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"SCULLY, Marie"', وقت الاستعلام: 1.35s تنقيح النتائج
  1. 1
    دورية أكاديمية
    The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.

    المؤلفون: Rondeau, Eric, Scully, Marie, Ariceta, Gema, Barbour, Tom, Cataland, Spero, Heyne, Nils, Miyakawa, Yoshitaka, Ortiz, Stephan, Swenson, Eugene, Vallee, Marc, Yoon, Sung-Soo, Kavanagh, David, Haller, Hermann, 311 Study Group, Goffin, Eric

    المساهمون: UCL - SSS/IREC/NEFR - Pôle de Néphrologie, UCL - (SLuc) Service de néphrologie

    المصدر: Kidney international, Vol. 97, no.6, p. 1287-1296 (2020)

    مصطلحات موضوعية: atypical hemolytic uremic syndrome, complement, eculizumab, hemolytic uremic syndrome, ravulizumab, thrombotic microangiopathy

    العلاقة: boreal:240266; http://hdl.handle.net/2078.1/240266Test; info:pmid/32299680; urn:EISSN:1523-1755

    الإتاحة: https://doi.org/10.1016/j.kint.2020.01.035Test
    http://hdl.handle.net/2078.1/240266Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome

    المؤلفون: Siedlecki, Andrew M, Isbel, Nicole, Vande Walle, Johan, Eggleston, Jennifer James, Cohen, David J, Licht, Christoph, Frémeaux-Bacchi, Véronique, Ariceta, Gema, Ardissino, Gianluigi, Fakhouri, Fadi, Greenbaum, Larry, Johnson, Sally, Schaefer, Franz, Scully, Marie Ann, Woodward, Leonard, Ogawa, Masayo, Gasteyger, Christoph, Blasco, Miquel, Cresseri, Donata, Generolova, Galina, Webb, Nicholas, Hirt-Minkowski, Patricia, Kozlovskaya, Natalya Lvovna, Landau, Danny, Lapeyraque, Anne-Laure, Loirat, Chantal, Mache, Christoph, Malina, Michal, Martola, Leena, Massart, Annick, Rondeau, Eric, Sartz, Lisa

    المصدر: KIDNEY INTERNATIONAL REPORTS ; ISSN: 2468-0249

    مصطلحات موضوعية: Medicine and Health Sciences, HUS, atypical hemolytic uremic syndrome, dialysis, eculizumab, kidney observational study, transplantation, COMPLEMENT INHIBITOR ECULIZUMAB, EFFICACY, OUTCOMES, SAFETY, AHUS, RECURRENCE, RECIPIENTS, GENES

    وصف الملف: application/pdf

    العلاقة: https://biblio.ugent.be/publication/8605450Test; http://hdl.handle.net/1854/LU-8605450Test; http://dx.doi.org/10.1016/j.ekir.2018.11.010Test; https://biblio.ugent.be/publication/8605450/file/8608302Test

    الإتاحة: https://doi.org/10.1016/j.ekir.2018.11.010Test
    https://biblio.ugent.be/publication/8605450Test
    http://hdl.handle.net/1854/LU-8605450Test
    https://biblio.ugent.be/publication/8605450/file/8608302Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome

    المؤلفون: Azoulay, Elie, Knoebl, Paul, Garnacho-Montero, José, Rusinova, Katerina, Galstian, Gennadii, Eggimann, Philippe, Abroug, Fekri, Benoit, Dominique, von Bergwelt-Baildon, Michael, Wendon, Julia, Scully, Marie

    المصدر: CHEST ; ISSN: 0012-3692

    مصطلحات موضوعية: Medicine and Health Sciences, atypical hemolytic uremic syndrome, eculizumab, intensive care, organ failure, plasma exchange, thrombocytopenia, thrombotic microangiopathy, THROMBOTIC THROMBOCYTOPENIC PURPURA, COMPLEMENT INHIBITOR ECULIZUMAB, CONSENSUS DOCUMENT, SYNDROME DIAGNOSIS, I TREAT, MICROANGIOPATHIES, AHUS, UPDATE, ACTIVATION, MANAGEMENT

    وصف الملف: application/pdf

    العلاقة: https://biblio.ugent.be/publication/8551926Test; http://hdl.handle.net/1854/LU-8551926Test; http://dx.doi.org/10.1016/j.chest.2017.03.055Test; https://biblio.ugent.be/publication/8551926/file/8551931Test

    الإتاحة: https://doi.org/10.1016/j.chest.2017.03.055Test
    https://biblio.ugent.be/publication/8551926Test
    http://hdl.handle.net/1854/LU-8551926Test
    https://biblio.ugent.be/publication/8551926/file/8551931Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy.

    المؤلفون: Neave, Lucy, Gale, Daniel P., Cheesman, Simon, Shah, Raakhee, Scully, Marie

    المصدر: British Journal of Haematology; Jul2019, Vol. 186 Issue 1, p113-124, 12p, 1 Diagram, 3 Charts, 1 Graph

    مصطلحات موضوعية: GENETIC disorders, THERAPEUTICS, COMPLEMENT inhibition, GLOMERULAR filtration rate, ECULIZUMAB


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.

    المؤلفون: Scully, Marie1, Goodship, Tim2

    المصدر: British Journal of Haematology. Mar2014, Vol. 164 Issue 6, p759-766. 8p.

    مصطلحات موضوعية: *THROMBOTIC thrombocytopenic purpura treatment, *ECULIZUMAB, *RITUXIMAB, *THROMBOTIC thrombocytopenic purpura, *MONOCLONAL antibodies, *THROMBOCYTOPENIA


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Emerging Therapies in Immune Thrombocytopenia.

    المؤلفون: Audia, Sylvain, Bonnotte, Bernard, Scully, Marie

    المصدر: Journal of Clinical Medicine; Mar2021, Vol. 10 Issue 5, p1004-1004, 1p

    مصطلحات موضوعية: IDIOPATHIC thrombocytopenic purpura, THROMBOPOIETIN receptors, PLASMA cells, BONE marrow, PROTEIN-tyrosine kinases, FC receptors, BLOOD platelet disorders, ECULIZUMAB, ESOPHAGEAL varices

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث